Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To compare patient perceptions of the sensory attributes, including taste and aftertaste, of
Olopatadine relative to azelastine when administered as a single dose in patients with
allergic rhinitis.